Korean J Physiol Pharmacol.
1999 Dec;3(6):539-546.
Effect of cytokines and bFGF on the osteoclast differentiation induced by 1 alpha,25-(OH)2D3 in primary murine bone marrow cultures
- Affiliations
-
- 1Department of Dental Pharmacology, Wonkwang University School of Dentistry, Iksan, Chonbuk, Korea.
- 2Wonkwang Dental Research Institute, School of Dentistry, Wonkwang University, Iksan, Chonbuk 570-749.
- 3Department of Oriental Pharmacy, School of Pharmacy, Wonkwang University, Iksan, Chonbuk 570-749.
- 4Department of Pharmacology, Chonbuk National University, Chonju, Chonbuk 560-180, Korea.
- 5Institute of Cardiovascular Research, School of Medicine, Chonbuk National University, Chonju, Chonbuk 560-180, Korea.
Abstract
-
Bone is a complex tissue in which resorption and formation continue
throughout life. The bone tissue contains various types of cells, of
which the bone forming osteoblasts and bone resorbing osteoclasts are
mainly responsible for bone remodeling. Periodontal disease represents
example of abnormal bone remodeling. Osteoclasts are multinucleated
cells present only in bone. It is believed that osteoclast progenitors
are hematopoietic origin, and they are recruited from hematopoietic
tissues such as bone marrow and circulating blood to bone. Cells
present in the osteoclast microenvironment include marrow stromal
cells, osteoblasts, macrophages, T-lymphocytes, and marrow cells. These
cells produce cytokines that can affect osteoclast formation. In vitro
model systems using bone marrow cultures have demonstrated that IL-1
beta, IL-3, TNF-alpha, bFGF can stimulate the formation of
osteoclasts. In contrast, IL-4 inhibits osteoclast formation. Knowledge
of cytokines and bFGF that affect osteoclast formation and their
capacity to modulate the bone-resorbing process should provide critical
insights into normal calcium homeostasis and disorders of bone turnover
such as periodontal disease, osteoporosis and Paget's disease.